ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG Asparaginase

NCT00819351 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

650

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: PEG Asparaginase at six weeks interval
DRUG: PEG Asparaginase at two weeks interval

Sponsor

Rigshospitalet, Denmark

Collaborators

[object Object]